Deciphering the Mechanism of Immune Dysfunction in Vici Syndrome

Table of Contents

Chapter 1 – INTRODUCTION

1.1) Vici Syndrome

1.2) EPG5

1.3) Autophagy and endocytosis

1.4) Pathogenesis of Vici Syndrome

1.5) Toll-like protein receptors (TLRs)

Chapter 2 – AIM OF THE WORK

Chapter 3 – MATERIALS AND METHODS

3.1) Materials

3.1.1) Patients clinical data

3.1.2) Cell Cultures

3.2) Methods

3.2.1) Isolation of Peripheral Blood Mononuclear Cells (PBMCs)

3.2.2) Generation of a lymphoblastoid cell lines

3.2.3) PBMCs stimulation with TLR2-9 agonists

3.2.4) Fibroblast stimulation with CpG or IL-1β and NF-kBp65 translocation

3.2.5) CpG-FITC internalization in lymphoblastoid cell lines (LCLs)

3.2.6) Immunofluorescence

3.2.7) Transient gene silencing by siRNA

3.2.8) Transient gene transfection by lipofection

3.2.9) Transient gene transfection by electroporation

3.2.10) Extraction of genomic DNA

3.2.11) Extraction and quantification of the RNA

3.2.12) Reverse transcription and amplification (RT-PCR)

3.2.13) Electrophoresis, extraction from the agarose gel and sequencing of PCR products

3.2.14) Amplification and quantification by real-time PCR

3.2.15) Protein extraction and quantification

3.2.16) Electrophoresis of proteins by SDS-polyacrylamide gel

3.2.17) Western blotting

3.2.18) Plasmid constructs and transformation of bacterial cells

3.2.19) Preparation of plasmid DNA

3.2.20) DQ-BSA internalization

Chapter 4 – RESULTS

4.1) Molecular genetic analysis

4.2) Analysis of the effects of mutations on the transcribed EPG5

4.3) Analysis of the effects of the mutations on protein EPG5

4.4) Stimulation of PBMC in vitro with TLR2-9 agonists

4.5) Detection of NF-kB p65

4.6) Analysis of intracellular transport of DQ-BSA

4.7) Analysis of intracellular transport of CpG (EAA1, LAMP1, LAMP2)

4.8) Internalization of CpG-FITC in the patient’s and control fibroblasts

4.9) Transient silencing of EPG5 and internalization of CpG-FITC

4.10) Cellular localization of EPG5 in HEK293T cell lines

Chapter 5 – DISCUSSION

Objectives and Research Themes

This thesis aims to decipher the underlying molecular mechanisms of immune dysfunction in Vici syndrome. Specifically, the research investigates how mutations in the EPG5 gene impact the autophagy and endocytic pathways, leading to the characteristic immunodeficiency observed in affected patients.

• Investigation of molecular defects caused by EPG5 mutations.
• Analysis of the endocytic pathway and late endosome-lysosome fusion.
• Evaluation of B cell response and TLR9 signaling alterations.
• Study of the impact of EPG5 gene silencing and overexpression on cellular phenotype.

Excerpt from the Book

Summary of Chapters

Chapter 1 – INTRODUCTION: Provides a comprehensive overview of Vici syndrome, the EPG5 gene, and the fundamental roles of autophagy, endocytosis, and Toll-like receptors in human immunity.

Chapter 2 – AIM OF THE WORK: Outlines the study's goal to investigate how EPG5 mutations disrupt molecular pathways, specifically addressing the observed immunodeficiency through autophagy and endocytosis analysis.

Chapter 3 – MATERIALS AND METHODS: Details the experimental procedures including patient clinical data, cell culture maintenance, gene silencing, immunofluorescence, and biochemical techniques like Western blotting and RT-PCR.

Chapter 4 – RESULTS: Presents findings from genetic analysis and cellular experiments, demonstrating that EPG5 mutations lead to defective fusion of late endosomes and lysosomes, impairing TLR9 signaling.

Chapter 5 – DISCUSSION: Synthesizes the results to propose Vici syndrome as a paradigm for multi-system disease caused by defective vesicular trafficking, highlighting the importance of EPG5 in cellular homeostasis.

Keywords

Vici syndrome, EPG5, Autophagy, Endocytosis, Immunodeficiency, Toll-like receptors, TLR9, Lysosomal fusion, Genetic mutations, Molecular biology, Cell signaling, NF-kB, Congenital disorder, Vesicular trafficking, Clinical immunology

Frequently Asked Questions

What is the core focus of this research?

The work investigates the molecular mechanisms behind the immune deficiency observed in patients with Vici syndrome, specifically linking the EPG5 gene to defects in autophagy and endocytosis.

What are the primary thematic areas explored?

The study centers on Vici syndrome pathophysiology, the role of the EPG5 gene, autophagy-endocytosis pathway integration, and Toll-like receptor (TLR) signaling dysfunction.

What is the central research question?

The research asks why defects in EPG5 expression cause immunodeficiency and seeks to define the role of this gene in the immune response and intracellular transport pathways.

Which scientific methods were employed?

Methodologies included RT-PCR, quantitative real-time PCR, Western blotting, confocal immunofluorescence, flow cytometry, gene silencing (siRNA), and plasmid-based transient transfection.

What does the main body cover?

It covers clinical descriptions, materials and protocols, genetic analysis, expression studies, and detailed experimental demonstrations of altered endocytic and autophagic transport in patient cells.

What key terms characterize the study?

Vici syndrome, EPG5, autophagy, endocytosis, and immunodeficiency are the most significant descriptors of the work.

How does Vici syndrome affect B cells?

Patients exhibit a reduction in memory B cells and a failure of B cells to respond to CpG, a ligand for the TLR9 receptor, leading to reduced antibody production.

What is the functional defect regarding the EPG5 gene?

The study demonstrates that EPG5 is essential for the late steps of the endocytic pathway, specifically the fusion of late endosomes with lysosomes, which is necessary for TLR9 signaling and autophagy.